stockportfolio.pro
Haemonetics Corporation Shares Outstanding 2009–2026
Haemonetics Corporation (HAE) annual shares outstanding by fiscal year, computed from SEC filings.
| Fiscal year | Shares Outstanding | Change (YoY) |
|---|---|---|
| FY 2026 | 45.3M | -6.1% |
| FY 2025 | 48.2M | -5.1% |
| FY 2024 | 50.8M | +0.7% |
| FY 2023 | 50.4M | -1.3% |
| FY 2022 | 51.1M | +0.5% |
| FY 2021 | 50.9M | +1.1% |
| FY 2020 | 50.3M | -1.4% |
| FY 2019 | 51.0M | -2.5% |
| FY 2018 | 52.3M | +0.2% |
| FY 2017 | 52.3M | +2.6% |
| FY 2016 | 50.9M | -1.4% |
| FY 2015 | 51.7M | -0.7% |
| FY 2014 | 52.0M | +2.0% |
| FY 2013 | 51.0M | +0.8% |
| FY 2012 | 50.6M | +0.0% |
| FY 2011 | 50.6M | -0.5% |
| FY 2010 | 50.9M | — |
| FY 2009 | 0.0M | — |
Source: Haemonetics Corporation SEC filings — balance sheet (10-K), split-adjusted. Refreshed nightly.
See the full picture for Haemonetics Corporation
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeHaemonetics Corporation — frequently asked questions
What is Haemonetics Corporation's shares outstanding?
Haemonetics Corporation (HAE) reported shares outstanding of 45.3M for fiscal year 2026, per its SEC filings.
Where does this data come from?
Figures are computed from Haemonetics Corporation's official SEC filings (balance sheet (10-K), split-adjusted), refreshed nightly. Not investment advice.